CAD 22.74
(-0.26%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 9.12 Billion | 11.61 Billion | 8.62 Billion | 6.2 Billion | 7.23 Billion | 7.35 Billion |
Cost of Revenue | 6.28 Billion | 8.48 Billion | 5.98 Billion | 4.19 Billion | 4.79 Billion | 5.02 Billion |
Gross Profit | 2.84 Billion | 3.12 Billion | 2.64 Billion | 2 Billion | 2.43 Billion | 2.32 Billion |
Operating Expenses | 185 Million | 528 Million | 58 Million | 228 Million | 311 Million | 306 Million |
Selling, General and Administrative Expenses | 422 Million | 399 Million | 306 Million | 246 Million | 296 Million | 279 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -237 Million | 129 Million | -248 Million | -18 Million | 15 Million | -274 Million |
Cost and Expenses | 6.47 Billion | 9.01 Billion | 6.03 Billion | 4.42 Billion | 5.1 Billion | 5.33 Billion |
Operating Income | 2.65 Billion | 2.59 Billion | 2.11 Billion | 1.78 Billion | 1.82 Billion | 2.02 Billion |
Interest Expense | 470 Million | 462 Million | 440 Million | 416 Million | 321 Million | 286 Million |
Income Tax Expense | 413 Million | 248 Million | 423 Million | -100 Million | 36 Million | 464 Million |
Earnings before Tax | 2.18 Billion | 3.21 Billion | 1.66 Billion | -416 Million | 1.52 Billion | 1.74 Billion |
Net Income | 1.77 Billion | 2.97 Billion | 1.24 Billion | -316 Million | 1.49 Billion | 1.27 Billion |
Earnings Per Share Basic | 3.00 | 5.14 | 2.00 | -0.57 | 2.69 | 2.53 |
Earnings Per Share Diluted | 2.99 | 5.13 | 1.99 | -0.57 | 2.68 | 2.51 |
Weighted Average Shares Outstanding | 550 Million | 553 Million | 550 Million | 550 Million | 512 Million | 505 Million |
Weighted Average Shares Outstanding (Diluted) | 551 Million | 554 Million | 551 Million | 550 Million | 514 Million | 509 Million |
Gross Margin | 0.31 | 0.27 | 0.31 | 0.32 | 0.34 | 0.32 |
EBIT Margin | 0.33 | 0.28 | 0.38 | 0.40 | 0.34 | 0.33 |
Profit Margin | 0.19 | 0.26 | 0.14 | -0.05 | 0.21 | 0.17 |
EBITDA | 3 Billion | 4 Billion | 2.54 Billion | 418 Million | 1.99 Billion | 2.43 Billion |
Earnings Before Tax Margin | 0.29 | 0.22 | 0.25 | 0.29 | 0.25 | 0.27 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 1.82 Billion | 1.59 Billion | 2.46 Billion | 9.12 Billion | 2.29 Billion | 2.07 Billion |
Cost of Revenue | 1.11 Billion | 978 Million | 1.61 Billion | 6.28 Billion | 1.63 Billion | 1.41 Billion |
Gross Profit | 708 Million | 619 Million | 850 Million | 2.84 Billion | 659 Million | 659 Million |
Operating Expenses | 100 Million | 96 Million | 150 Million | 416 Million | 87 Million | 93 Million |
Selling, General and Administrative Expenses | 100 Million | 96 Million | 142 Million | - | 104 Million | 84 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 540 Million | - | - | - | - | - |
Cost and Expenses | 1.21 Billion | 1.07 Billion | 1.76 Billion | 6.7 Billion | 1.72 Billion | 1.5 Billion |
Operating Income | 608 Million | 523 Million | 931 Million | 2.65 Billion | 572 Million | 566 Million |
Interest Expense | 154 Million | 131 Million | 117 Million | 470 Million | 119 Million | 118 Million |
Income Tax Expense | -506 Million | 91 Million | 117 Million | 413 Million | 96 Million | 94 Million |
Earnings before Tax | -88 Million | 378 Million | 815 Million | 2.18 Billion | 442 Million | 457 Million |
Net Income | 471 Million | 438 Million | 698 Million | 1.77 Billion | 346 Million | 363 Million |
Earnings Per Share Basic | 0.75 | 0.74 | 1.21 | - | 0.58 | 0.60 |
Earnings Per Share Diluted | 0.75 | 0.73 | 1.21 | - | 0.57 | 0.60 |
Weighted Average Shares Outstanding | 580 Million | 549 Million | 549 Million | 550 Million | 549 Million | 550 Million |
Weighted Average Shares Outstanding (Diluted) | 581 Million | 550 Million | 550 Million | 551 Million | 550 Million | 551 Million |
Gross Margin | 0.39 | 0.39 | 0.34 | 0.31 | 0.29 | 0.32 |
EBIT Margin | 0.47 | 0.43 | 0.36 | - | 0.32 | 0.35 |
Profit Margin | 0.26 | 0.27 | 0.28 | 0.19 | 0.15 | 0.18 |
EBITDA | 853 Million | 684 Million | 878 Million | - | 736 Million | 732 Million |
Earnings Before Tax Margin | 0.33 | 0.33 | 0.38 | 0.29 | 0.25 | 0.27 |
JBCHEPHARM
BASC
SAURASHCEM
300552
ARCHIDPLY
SEB